Search - tctmd.com

Displaying 601 - 620 of 700

Sort: Relevancy | Date

News Conference News ESC 2015

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Yael L. Maxwell

August 30, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 28, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

June 24, 2015

News Industry News

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

June 22, 2015

News Industry News

Expert panel publishes guidance for central aortic pressure waveform analysis in patient care

May 27, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Industry News

Study conducted at the Minneapolis Heart Institute Foundation finds World's Small Pacemaker meets initial Safety and Performance Measures

May 21, 2015

News Daily News

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

L.A. McKeown

April 03, 2015

News Daily News

Early Discharge Feasible, Safe for Selected Elderly STEMI Patients

Yael L. Maxwell

March 26, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

L.A. McKeown

February 22, 2015

Advertisement

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

World's Smallest Pacemaker, Medtronic Micra TPS, Wins Top European Innovation Award for 2015

World's Smallest Pacemaker, Medtronic Micra TPS, Featured in Late-Breaking Trial Session at EUROPACE 2015

Expert panel publishes guidance for central aortic pressure waveform analysis in patient care

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Study conducted at the Minneapolis Heart Institute Foundation finds World's Small Pacemaker meets initial Safety and Performance Measures

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

Early Discharge Feasible, Safe for Selected Elderly STEMI Patients

Analysis of SYNTAX Patients Documents Underuse of OMT

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content